ZA89447B - Composition and method for protecting against diseases caused by microorganisms - Google Patents

Composition and method for protecting against diseases caused by microorganisms

Info

Publication number
ZA89447B
ZA89447B ZA89447A ZA89447A ZA89447B ZA 89447 B ZA89447 B ZA 89447B ZA 89447 A ZA89447 A ZA 89447A ZA 89447 A ZA89447 A ZA 89447A ZA 89447 B ZA89447 B ZA 89447B
Authority
ZA
South Africa
Prior art keywords
nuclease
protecting against
microorganisms
composition
diseases caused
Prior art date
Application number
ZA89447A
Other languages
English (en)
Inventor
Daryl H Faulds
H Faulds Daryl
Mimi Vishoot
Vishoot Mimi
Original Assignee
Ml Technology Ventures
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Technology Ventures filed Critical Ml Technology Ventures
Publication of ZA89447B publication Critical patent/ZA89447B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fodder In General (AREA)
ZA89447A 1988-01-20 1989-01-19 Composition and method for protecting against diseases caused by microorganisms ZA89447B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/146,256 US4985243A (en) 1988-01-20 1988-01-20 Composition and method for protecting against diseases caused by microorganisms

Publications (1)

Publication Number Publication Date
ZA89447B true ZA89447B (en) 1989-10-25

Family

ID=22516535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89447A ZA89447B (en) 1988-01-20 1989-01-19 Composition and method for protecting against diseases caused by microorganisms

Country Status (11)

Country Link
US (1) US4985243A (de)
EP (1) EP0325191B1 (de)
JP (1) JPH0768142B2 (de)
AT (1) ATE127693T1 (de)
DE (1) DE68924183T2 (de)
DK (1) DK22389A (de)
ES (1) ES2078900T3 (de)
GR (1) GR3017427T3 (de)
IE (1) IE890141L (de)
PT (1) PT89488A (de)
ZA (1) ZA89447B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
ATE160699T1 (de) * 1990-05-29 1997-12-15 American Cyanamid Co Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
PT839050E (pt) * 1992-09-28 2004-11-30 Wyeth Corp Metodo de melhorar respostas imunes mediadas por celulas
US5498527A (en) * 1994-02-18 1996-03-12 Ube Industries, Ltd. Phosphorylcholine-containing glyceroglycolipid
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
EP1666055A4 (de) * 2003-07-14 2010-02-10 Viktor Veniaminovich Tets Verfahren zur behandlung von onkologischen, virulenten und somatischen erkrankungen, verfahren zur kontrolle der behandlungseffizienz, pharmazeutische mittel und zusammensetzung zur durchführung dieser behandlung
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
EP1880733A4 (de) 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich Verfahren zur verlängerung der lebensdauer eines menschen und von tieren
AU2006289626A1 (en) * 2005-09-09 2007-03-15 Universitat Zurich Antigens for vaccination against and detection of Mycoplasma suis
KR20090087095A (ko) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 조직의 세포외공간에서 증가된 데옥시리보핵산 함량과 관련된 인간 질병을 치료하는 방법 및 이 방법을 수행하기 위한 약학 제제
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
CN104784465B (zh) * 2015-04-14 2017-11-03 中国农业科学院兰州畜牧与兽药研究所 一种用于防治猪气喘病的中药组合物及其制备方法和应用
RU2726131C2 (ru) 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Внеклеточная днк в качестве терапевтической мишени при нейродегенерации
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
CN109234253B (zh) * 2018-09-19 2021-02-19 中国农业大学 Mhp非特异性核酸酶及其编码基因与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485721A (en) * 1968-04-24 1969-12-23 Merck & Co Inc Process for growing mycoplasma pneumonial organisms
US4123427A (en) * 1976-07-27 1978-10-31 Daniel Thomas M Method for the purification of mycobacterial protein antigens and resulting product
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4666851A (en) * 1985-04-25 1987-05-19 Lee Sin H Specific mycoplasma membrane antigen and antibody and their clinical applications

Also Published As

Publication number Publication date
EP0325191A3 (en) 1990-04-04
DE68924183T2 (de) 1996-03-21
JPH0768142B2 (ja) 1995-07-26
PT89488A (pt) 1989-10-04
EP0325191A2 (de) 1989-07-26
ES2078900T3 (es) 1996-01-01
JPH02711A (ja) 1990-01-05
GR3017427T3 (en) 1995-12-31
ATE127693T1 (de) 1995-09-15
DK22389D0 (da) 1989-01-19
DK22389A (da) 1989-07-21
US4985243A (en) 1991-01-15
IE890141L (en) 1989-07-20
EP0325191B1 (de) 1995-09-13
DE68924183D1 (de) 1995-10-19

Similar Documents

Publication Publication Date Title
GR3017427T3 (en) Composition and method for protecting against diseases caused by microorganisms.
AU4921590A (en) Pf 1022 substance, method of producing same and anthelmintic composition containing same
CA1262357A (en) N-HYDROXYL PROTECTIVE GROUPS AND METHOD FOR THE PREPARATION OF 3-ACYLAMINO-1-HYDROXY-2-AZETIDINONES
CA2211522A1 (en) Novel compounds
ATE197765T1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
NZ209635A (en) Pharmaceutical composition containing extract from microorganism and detoxified endotoxin
FI952148L (fi) Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi
KR0148212B1 (en) Phenylalkan (en)oic acids
IL115627A0 (en) Preparation of substituted 3-aminobenzonitriles
EP0529019A4 (en) Nematode vaccine
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
ATE161051T1 (de) Verfahren zur herstellung aktivierter sialinsäuren
WO1987005906A3 (en) Protecting groups for organic synthesis
EP0289804A3 (de) Verfahren zur Herstellung von optisch aktiven Mercapto-Verbindungen
GR74471B (de)
DE3869885D1 (de) Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters.
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ATE156131T1 (de) Verbessertes verfahren zur herstellung von 2- amino(2,3,5-tri-o-benzyl-beta-d- arabinofuranosyl)adenin
ATE9477T1 (de) Verfahren zur herstellung von 1,1'-diacetalen.
DE3371633D1 (en) A process for preparing oxanosine
JPS5799599A (en) Novel muramic acid derivative
FR2697837B1 (fr) Procédé de préparation d'octadienols.